Computational Biology Market 2019 Top Players: ACCELRYS, CERTARA, CHEMICAL COMPUTING GROUP, COMPUGEN LTD, ENTELOS, GENEDATA AG, INSILICO BIOTECHNOLOGY AG

Computational biology is defined as the application of mathematical models, theoretical methods and computer aided simulation for the study of behavioral, social and biological systems. It is an interdisciplinary field, which includes the principles of applied mathematics, computer science, statistics, genomics, genetics, animation, visualization and a lot more. It makes use of biological data to construct relationship models and algorithms between different biological systems to analyze the differences and similarities among them. The various segments of the industry include computational genomics, computational neuroscience, computational bio-modeling, computational pharmacology, evolutionary biology and cancer research. The global computational biology market is expected to register a CAGR of 19.5% during the forecast period (2018 u2013 2023).

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16759

Increase in Bioinformatics Research
Bioinformatics is the use of IT in biotechnology for the data storage, data warehousing and analyzing the DNA sequences. There are many applications of bioinformatics and its usage has been seen in Microbial genome applications, Molecular medicine, Personalized medicine, Preventative medicine, Gene therapy, Drug development, Antibiotic resistance, Evolutionary studies, Waste cleanup, Biotechnology and many other places. This has led to an increasing research in this field, which further requires the use of computational methods.
Also, increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug development and growth of drug designing, disease modeling and personalized medicine are some other drivers of the market.

Key Developments in the Market
• February 2018: Certara has recently acquired BaseCase, a Life Sciences Data Visualization company.
• February 2018: Schru00f6dinger launched Cryo-EM Initiative (SCI) to develop breakthrough medicines using cryo-electron microscopy (Cryo-EM) technology.

Key players:
ACCELRYS, CERTARA, CHEMICAL COMPUTING GROUP INC., COMPUGEN LTD, ENTELOS, GENEDATA AG, INSILICO BIOTECHNOLOGY AG, LEADSCOPE INC, NIMBUS DISCOVERY LLC, RHENOVIA PHARMA SAS, SCHRODINGER, SIMULATION PLUS INC among others.

Request Discount on this repots @ https://marketprognosis.com/discount-request/16759

Lack of Trained Professionals
Computational biology involves development and application of software, analytical and theoretical methods, mathematical modelling and other computational techniques used for study of biological, behavioral and social systems. This development and application requires use of trained professionals so as to make correct analysis. However, due to the lack of properly trained professionals hampers the market growth.

North America to Dominate the Market
The global computational biology market is segmented by drug type, therapeutic indication and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the market due to growing initiatives and investments for R&D of drug discovery, novel drugs, disease modeling, and technological advancements in biological computations.

Enquiry Before Buying @ https://marketprognosis.com/enquiry/16759

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.